Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

Caitlin E. Cox

July 11, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

Todd Neale

June 02, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Daily News

Mechanical Stroke Thrombectomy May Reduce Death: Meta-analysis

Todd Neale

September 14, 2021

News Daily News

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

Caitlin E. Cox

February 11, 2021

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

Advertisement

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Physicians (Mostly) Negative on Private Equity in Healthcare

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Experts Warn of Looming Private Equity Interest in Cardiology Care

AHA Selects 2023’s Leading Cardiovascular Research

TCTMD’s Top 10 Most Popular Stories for September 2023

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

Only Half of Revascularized PAD Patients Receive GDMT

Worse Complications After PVI in Women Highlight Research Gaps

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

PAD Significantly Ups Morbidity and Mortality in AMICS

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

TCTMD’s Top 10 Most Popular Stories for November 2021

Mechanical Stroke Thrombectomy May Reduce Death: Meta-analysis

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content